Polyrizon Ltd.’s (NASDAQ:PLRZ) Quiet Period Set To End on December 9th

Polyrizon’s (NASDAQ:PLRZ) quiet period is set to expire on Monday, December 9th. Polyrizon had issued 958,903 shares in its initial public offering on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Polyrizon Price Performance

Polyrizon stock opened at $0.99 on Friday. Polyrizon has a 52 week low of $0.77 and a 52 week high of $1.97.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.